Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (271-280 of 484) with videos related to

Pageof 49
Sort By:
Rheumatology (Oxford, England)|October 14, 2024
Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTULJulia Spierings, Paco M J Welsing, Seda Colak, et al.
Arthritis and Rheumatism|July 11, 2013
Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertensionEmma C Derrett-Smith, Audrey Dooley, Adrian J Gilbane, et al.
Annals of the Rheumatic Diseases|June 23, 2019
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysisMike Becker, Nicole Graf, Rafael Sauter, et al.
Seminars in Arthritis and Rheumatism|June 8, 2024
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort studyKimberly S Lakin, Yin Wu, Jessica K Gordon, et al.
JCI Insight|April 23, 2024
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertensionIoannis Papaioannou, Athina Dritsoula, Ping Kang, et al.
The American Journal of Pathology|December 7, 2006
Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healingVineeth S Rajkumar, Xu Shiwen, Maria Bostrom, et al.
Rheumatology (Oxford, England)|November 3, 2016
Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumourCosimo Bruni, Ana Lages, Hitesh Patel, et al.
The Journal of Biological Chemistry|April 23, 2003
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic miceChristopher P Denton, Bing Zheng, Lowri A Evans, et al.
Arthritis and Rheumatism|May 29, 2007
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progressionNicole S L Goh, Srihari Veeraraghavan, Sujal R Desai, et al.
Rheumatology (Oxford, England)|September 16, 2022
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trialChristopher P Denton, Nicole S Goh, Stephen M Humphries, et al.
Pageof 49

Showing results (271-280 of 484) with videos related to

Sort By:
Pageof 49
Rheumatology (Oxford, England)|October 14, 2024
Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTULJulia Spierings, Paco M J Welsing, Seda Colak, et al.
Arthritis and Rheumatism|July 11, 2013
Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertensionEmma C Derrett-Smith, Audrey Dooley, Adrian J Gilbane, et al.
Annals of the Rheumatic Diseases|June 23, 2019
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysisMike Becker, Nicole Graf, Rafael Sauter, et al.
Seminars in Arthritis and Rheumatism|June 8, 2024
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort studyKimberly S Lakin, Yin Wu, Jessica K Gordon, et al.
JCI Insight|April 23, 2024
NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertensionIoannis Papaioannou, Athina Dritsoula, Ping Kang, et al.
The American Journal of Pathology|December 7, 2006
Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healingVineeth S Rajkumar, Xu Shiwen, Maria Bostrom, et al.
Rheumatology (Oxford, England)|November 3, 2016
Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumourCosimo Bruni, Ana Lages, Hitesh Patel, et al.
The Journal of Biological Chemistry|April 23, 2003
Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic miceChristopher P Denton, Bing Zheng, Lowri A Evans, et al.
Arthritis and Rheumatism|May 29, 2007
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progressionNicole S L Goh, Srihari Veeraraghavan, Sujal R Desai, et al.
Rheumatology (Oxford, England)|September 16, 2022
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trialChristopher P Denton, Nicole S Goh, Stephen M Humphries, et al.
Pageof 49